Schulte-Herbrüggen O, Braun A, Rochlitzer S, Jockers-Scherübl M C, Hellweg R
Department of Psychiatry and Psychotherapy, Charité-University Medicine Berlin, Campus Benjamin Franklin, Germany.
Curr Med Chem. 2007;14(22):2318-29. doi: 10.2174/092986707781745578.
Nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) belong to the protein family of neurotrophins. They both display profound neuromodulatory functions and are essentially involved in the survival and homeostatic maintenance of central and peripheral neurons during development and adulthood. Moreover, NGF and BDNF are known to modulate immune cell function and thus serve as mediators in the reciprocal cross talk between neurons and immune cells. Neurotrophic factors have been implicated in pathophysiological mechanisms of many diseases of the nervous and the immune system, such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), neuropathy, pain, allergic bronchial asthma (BA) and neurotrophic keratitis. For all these diseases research has reached the point of creating strategies for therapeutic intervention with neurotrophins. In this review, we present an overview of the pathophysiology, therapeutic interventions and strategies concerning NGF and BDNF in the mentioned diseases.
神经生长因子(NGF)和脑源性神经营养因子(BDNF)属于神经营养蛋白家族。它们都具有深刻的神经调节功能,在发育和成年期对中枢和外周神经元的存活及稳态维持起着至关重要的作用。此外,已知NGF和BDNF可调节免疫细胞功能,因此在神经元与免疫细胞之间的相互作用中充当介质。神经营养因子已被证实与许多神经和免疫系统疾病的病理生理机制有关,如肌萎缩侧索硬化症(ALS)、阿尔茨海默病(AD)、神经病变、疼痛、过敏性支气管哮喘(BA)和神经营养性角膜炎。对于所有这些疾病,研究已达到制定用神经营养因子进行治疗干预策略的阶段。在本综述中,我们概述了上述疾病中与NGF和BDNF相关的病理生理学、治疗干预措施及策略。